Speaker: Rob Ballinger Development Associate IV, Biological Process Development Alexion Pharmaceuticals, Inc.
Abstract: Mammalian cell line generation is a rate-limiting step in early CMC development and there is a constant desire to increase throughput. The implementation of automation is one way to increase throughput. This webinar will address some factors to consider during the process of automating a manual workflow including details of culture vessel changes, liquid handling adaptation, and changes of the cell line developer’s job during the process. With an end result of increased throughput, automation potentially allows cell line development to begin prior to final molecule selection. This can remove cell line development off the critical path of CMC development.
Key Learning Objectives:
Adjustments required to a manual cell line development workflow to evolve into an automated liquid handling workflow
How to optimize pipette tip selection in an automated cell line development workflow
How lab roles evolve with the addition of an automated liquid handler
Learn More: becls.co/3A599hW
MAPSS Approval Code: AAG-5233WEB04.19
Disclaimer: These products are not intended or validated for use in the diagnosis of disease or other conditions. © 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein, including Biomek, are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. Echo and Access are trademarks or registered trademarks of Labcyte Inc. in the United States and other countries. Labcyte is a Beckman Coulter company. All other trademarks are the property of their respective owners.
29 сен 2024
